Stock-Based Compensation |
8.
Stock-Based
Compensation
A
summary of the Company’s outstanding stock option activity for the three months ended March 31, 2022, and 2021 is as follows:
Summary of Stock Option Activity
|
|
|
|
|
March 31, 2022 |
|
|
|
|
|
|
|
|
|
Weighted- Average
|
|
|
Weighted- Average Remaining Contractual Life
|
|
|
Intrinsic |
|
|
|
Options |
|
|
Exercise Price |
|
|
(Years) |
|
|
Value |
|
As of December 31, 2021 |
|
|
833,892 |
|
|
$ |
3.91 |
|
|
|
8.7 |
|
|
|
87,553 |
|
Granted |
|
|
357,000 |
|
|
|
0.49 |
|
|
|
10.0 |
|
|
|
- |
|
Exercised |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
Forfeited |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
Expired |
|
|
(3 |
) |
|
|
139,237.86 |
|
|
|
- |
|
|
|
- |
|
As of March 31, 2022 |
|
|
1,190,889 |
|
|
$ |
2.38 |
|
|
|
8.9 |
|
|
$ |
114,500 |
|
Exercisable at March 31, 2022 |
|
|
387,212 |
|
|
$ |
6.02 |
|
|
|
8.3 |
|
|
$ |
44,652 |
|
Vested and expected to vest at March 31, 2022 |
|
|
1,178,659 |
|
|
$ |
2.44 |
|
|
|
8.9 |
|
|
$ |
117,100 |
|
|
|
|
|
|
March 31, 2021 |
|
|
|
|
|
|
|
|
|
Weighted- Average
|
|
|
Weighted- Average Remaining Contractual Life
|
|
|
Intrinsic |
|
|
|
Options |
|
|
Exercise Price |
|
|
(Years) |
|
|
Value |
|
As of December 31, 2020 |
|
|
465,393 |
|
|
$ |
5.53 |
|
|
|
9.3 |
|
|
|
- |
|
Granted |
|
|
368,500 |
|
|
|
1.93 |
|
|
|
10.0 |
|
|
|
- |
|
Exercised |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
Forfeited |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
Expired |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
As of March 31, 2021 |
|
|
833,893 |
|
|
$ |
3.98 |
|
|
|
9.4 |
|
|
$ |
698,913 |
|
Exercisable at March 31, 2021 |
|
|
376 |
|
|
$ |
6,977.42 |
|
|
|
4.1 |
|
|
$ |
- |
|
Vested and expected to vest at March 31, 2021 |
|
|
833,893 |
|
|
$ |
3.98 |
|
|
|
9.4 |
|
|
$ |
698,913 |
|
The
Company estimates the fair value of each stock option on the grant date using the Black-Scholes-Merton valuation model, which requires
several estimates including an estimate of the fair value of the underlying common stock on grant date. The expected volatility was based
on an average of the historical volatility of the Company. The expected term was contractual life of option. The risk-free interest rate
was based on the U.S. Treasury yield curve in effect at the time of grant for the expected term of the option. The following weighted
average assumptions were used in the calculation to estimate the fair value of options granted to employees and non-employees during
the three months ended March 31, 2022. During the three months ended March 31, 2022, the Company granted stock options
with an estimated fair value of approximately $0.2
million.
Schedule of Assumption Used for Fair value of Option
|
|
March 31, 2022 |
|
Weighted-average risk-free interest rate |
|
|
1.66 |
% |
Weighted-average expected life (in years) |
|
|
5.3-10 |
|
Expected dividend yield |
|
|
- |
% |
Weighted-average expected volatility |
|
|
130%-132 |
% |
Of
the 357,000
options granted during the three months ended
March 31, 2022, 60,000
were to non-executive members of the board of
directors. Of the 1,190,889
options outstanding as of March 31, 2022,
355,000
were awarded to non-executive members of the
board of directors.
Unrecognized
stock-based compensation as of March 31, 2022, is as follows (in thousands):
Schedule of Unrecognized Stock-based Compensation
|
|
|
|
|
Weighted Average
|
|
|
|
Unrecognized Stock-Based
|
|
|
Remaining of Recognition
|
|
|
|
Compensation |
|
|
(in years) |
|
Stock options |
|
$ |
609 |
|
|
|
2.0 |
|
Stock grants |
|
$ |
44 |
|
|
|
2.1 |
|
|